Figure 1
From: Anti-inflammation-based treatment of atherosclerosis using Gliclazide-loaded biomimetic nanoghosts
A macrophage-guided biomimetic platform designed here against atherosclerosis. A macrophage-guided biomimetic platform with anti-inflammatory agent, Gliclazide (GL), encapsulated in PLGA nanoparticles and overall coated with monocyte membrane with extrusion technique to generate pharmaceutically applicable nanoghosts for warding off atherosclerosis.
